1. Mansel RE, Goyal A, European studies on breast lymphatic mappingSemin Oncol 31:304–310, 2004
2. Mansel RE, Goyal A, Fallowfield L, Newcombe RG: Sentinel node biopsy versus standard axillary treatment: results of the randomized multicenter UK ALMANAC trial. Abstracts of the 27th Annual San Antonio Breast Cancer Symposium. December 8–11, 2004, San Antonio, Texas, USA. Breast Cancer Res Treat 88(Suppl 1): S1–S265, 2004
3. Mansel RE, Goyal A, Fallowfield L, Newcombe RG: First results of the randomized multicenter ALMANAC trial. Abstracts of the 40th Annual Meeting of the American Society of Clinical Oncology. New Orleans, Louisiana, USA, June 5–8, 2004. J Clin Oncol 22: 1s–1069s, 2004
4. Schrenk P, Rieger R, Shamiyeh A, Wayand W, Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinomaCancer 88: 608–614, 2000
5. Temple LK, Baron R, Cody HS III, Fey JV, Thaler HT, Borgen PI, Heerdt AS, Montgomery LL, Petrek JA, Van Zee KJ, Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 womenAnn Surg Oncol9: 654–662, 2002